The Discovery and Development of Selective Estrogen Receptor Modulators (SERMs) for Clinical Practice
Current Clinical Pharmacology · 01.03.2013 · 8 (2) · 135-155
DOI: 10.2174/1574884711308020006 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Current Clinical Pharmacology, erschienen am 01.03.2013. Verfasst von Philipp Y Maximov und 2 weiteren Autor:innen. Beteiligte Einrichtung: Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20057, USA. Die Arbeit wurde bisher 333-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20057, USA.
Förderung
- NCI NIH HHS
Zitieren
APA
Maximov, P. Y., Lee, T. M., & Jordan, V. C. (2013). The Discovery and Development of Selective Estrogen Receptor Modulators (SERMs) for Clinical Practice. Current Clinical Pharmacology, 8(2), 135-155. https://doi.org/10.2174/1574884711308020006
Vancouver
Maximov PY, Lee TM, Jordan VC. The Discovery and Development of Selective Estrogen Receptor Modulators (SERMs) for Clinical Practice. Current Clinical Pharmacology. 2013;8(2):135-155. doi:10.2174/1574884711308020006
BibTeX
@article{Maximov2013,
author = {Maximov, Philipp Y and Lee, Theresa M and Jordan, V Craig},
title = {The Discovery and Development of Selective Estrogen Receptor Modulators (SERMs) for Clinical Practice},
journal = {Current Clinical Pharmacology},
year = {2013},
volume = {8},
number = {2},
pages = {135--155},
doi = {10.2174/1574884711308020006}
}
EUVIMED